medmix AG (MEDX) — Cash Flow Reinvestment Rate

Latest as of December 2025: 0.50x

medmix AG (MEDX) has a Cash Flow Reinvestment Rate of 0.50x as of December 2025, reinvesting CHF18.80 Million (capex CHF18.80 Million ) from operating cash flow of CHF37.40 Million. Check how high is medmix AG's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.50x
(Capex + Investments) / Operating CF

Total Reinvested

CHF18.80 Million
Capex + Investments

Operating Cash Flow

CHF37.40 Million
CHF

Capital Expenditures

CHF18.80 Million
CHF

medmix AG Cash Flow Reinvestment Rate (2018–2025)

Historical reinvestment intensity for medmix AG across 8 annual periods. Explore MEDX operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for medmix AG (2018–2025)

Year-by-year capital reinvestment analysis for medmix AG. For live market cap and broader valuation context, see market cap of medmix AG.

Year Reinvestment Rate Total Reinvested (CHF) Operating CF Capex YoY Change
2025 0.51x CHF34.50 Million CHF67.80 Million CHF34.50 Million ▼ -55.9%
2024 1.15x CHF100.00 Million CHF86.60 Million CHF48.50 Million ▼ -51.5%
2023 2.38x CHF133.50 Million CHF56.10 Million CHF52.90 Million ▲ +18.5%
2022 2.01x CHF95.60 Million CHF47.60 Million CHF38.60 Million ▲ +177.9%
2021 0.72x CHF63.10 Million CHF87.30 Million CHF31.90 Million ▼ -57.8%
2020 1.71x CHF86.60 Million CHF50.60 Million CHF43.10 Million ▲ +252.2%
2019 0.49x CHF43.30 Million CHF89.10 Million CHF36.20 Million ▲ +23.4%
2018 0.39x CHF37.10 Million CHF94.20 Million CHF30.00 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow